778 results on '"Misawa, Sonoko"'
Search Results
152. O-3-1. Sequential electrodiagnosis can contribute to differentiating subtypes of Guillain-Barré syndrome
153. P1-4-01. Evaluation of small fiber involvement using pain-related evoked potentials in patients with type 1 and type 2 diabetes
154. O-3-39. Distribution of fasciculations in amyotrophic lateral sclerosis: An ultrasonographic study
155. O-3-02. The Involvement of sensory fibers in acute motor axonal neuropathy (AMAN)
156. Reversal of pulmonary arterial hypertension in POEMS syndrome with thalidomide: a case report
157. Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain
158. Practical Guide to the Differential Diagnosis of Neuromuscular Diseases
159. Post-Polio-Like Syndrome
160. 治験実施計画書 別紙1 変更点一覧 : ギラン・バレー症候群におけるエクリズマブの安全性と有効性を評価するための前向き、多施設共同、第Ⅱ相試験
161. Management of immune-related adverse events (irAEs) in clinical practice, support team of Chiba University Hospital
162. Pain-related evoked potentials after intraepidermal electrical stimulation to Aδ and C fibers in patients with neuropathic pain
163. Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome
164. Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies
165. Distinctive Genetic Features of Plasma Cells in POEMS Syndrome
166. Clonal Immunoglobulin λ Light-Chain Gene Rearrangements Detected By Next Generation Sequencing in POEMS Syndrome
167. 治験実施計画書 : ギラン・バレー症候群におけるエクリズマブの安全性と有効性を評価するための前向き、多施設共同、第Ⅱ相試験
168. 治験実施計画書 別紙1 : ギラン・バレー症候群におけるエクリズマブの安全性と有効性を評価するための前向き、多施設共同、第Ⅱ相試験
169. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome
170. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
171. Proposal of new clinical diagnostic criteria for POEMS syndrome.
172. Altered grey matter brain volume in patients with painful diabetic peripheral neuropathy; A voxel-based morphometry study
173. Future treatment for Guillain–Barré syndrome
174. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome
175. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial
176. Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis
177. POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification
178. Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis
179. Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis
180. Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study.
181. Acquired and genetic channelopathies: in vivo assessment of axonal excitability
182. Reduction of Optic Disc Oedema by Bortezomib and Dexamethasone Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patient with POEMS Syndrome.
183. Proposal of new clinical diagnostic criteria for POEMS syndrome
184. Increased IP-10 production by blood–nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy
185. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome
186. A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial
187. Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome (P3.171)
188. Delayed facial weakness in Guillain-Barré and miller fisher syndromes
189. Acquired and genetic channelopathies: In vivo assessment of axonal excitability
190. Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy
191. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome
192. Focal shoulder seizures due to an acute small cortical infarction located medial to precentral knob
193. Dilated cardiomyopathy with centronuclear myopathy in a young male
194. Duration of the Distal Compound Muscle Action Potential for Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
195. Severity and Patterns of Blood-Nerve Barrier Breakdown in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Correlations with Clinical Subtypes
196. Fasciculations, axonal hyperecitability, and motoneuronal death in amyotrophic lateral sclerosis
197. Exercise, dominant hand and neurodegeneration
198. Bortezomib-induced neuropathy: Axonal membrane depolarization precedes development of neuropathy
199. Safety and Efficacy of Intravenous Ultra-high Dose Methylcobalamin Treatment for Peripheral Neuropathy: A Phase I/II Open Label Clinical Trial
200. Motor nerve hyperexcitability in ALS: its pathophysiology and treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.